Autres langues Chiome Bioscience Inc.

Actions

4583

JP3205350006

Marché Fermé - Japan Exchange Autres places de cotation 08:00:00 02/05/2024			Varia. 5j.	Varia. 1 janv.
123 ^JPY	-2,38 %		0,00 %	-8,89 %

13/02	Chiome Bioscience Inc. annonce un accord de mandat avec Takeda Pharmaceutical Company Limited	CI
13/02	Chiome Bioscience Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Chiome Bioscience Cancels License Agreements with ADC Therapeutics	01/04
Chiome Bioscience Inc. Announces Entrustment Agreement with Takeda Pharmaceutical Company Limited	13/02
Chiome Bioscience Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	13/02
Chiome Bioscience Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	14/11
Chiome Bioscience Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	09/08/23
Chiome Bioscience Inc. announced that it has received ¥13.49304 million in funding from Barclays Bank PLC (Tokyo Branch), Growth Capital, Inc.	20/07/23
Chiome Bioscience Inc. announced that it expects to receive Â¥13.49304 million in funding	04/07/23
Chiome Bioscience Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	11/05/23
Chiome Bioscience Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	14/02/23
Chiome Bioscience Inc. Provided Sales Guidance for 2023	14/02/23
Henlius Biotech Terminates License Agreement for Chiome Bioscience's Tumor Drug	17/01/23
Chiome Bioscience Inc. Announces Termination of the License Agreement for Anti-TROP-2 Antibody Development and Commercialization with Shanghai Henlius Biotech, Inc	17/01/23
Chiome Bioscience Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022	14/11/22
Chiome Bioscience Reports Results of Cancer Immunotherapy Joint Research	09/09/22
Chiome Bioscience Signs Research and Option Agreement with Heidelberg Pharma	14/07/22
Heidelberg Pharma Enters Research Collaboration Deal With Japan's Chiome Bioscience	13/07/22
Chiome Bioscience : Announcement of target-specific research and option agreement with Heidelberg Pharma	13/07/22
Chiome Bioscience Inc. Announces Conclusion of Target-Specific Research and Option Agreement with Heidelberg Pharma	13/07/22
Japan Index Snaps Three-day Winning Streak on Inflationary Pressures; Kudan Shares Expand 7%	12/07/22
Chiome Bioscience, Rohto Pharmaceutical Sign Deal for Generation of Therapeutic Antibody	12/07/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Chiome Bioscience Inc.

Actions

4583

JP3205350006

Autres langues

Filtres